Matches in Nanopublications for { ?s ?p "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP272220.RAYXplYmotE3-ygjAMnwpBhLcH8TLGDxkugGRVvOY3sHM130_assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272220.RAYXplYmotE3-ygjAMnwpBhLcH8TLGDxkugGRVvOY3sHM130_provenance.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_provenance.
- NP1134237.RAVV4vVW6_D7vru8VSAH8E2g7_ne2MVWY9tykHCXsTPv8130_assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134237.RAVV4vVW6_D7vru8VSAH8E2g7_ne2MVWY9tykHCXsTPv8130_provenance.
- NP1134238.RArU3nKqsqfkEhyp5I8gXA2BlGbtmGlAz9tAG-exNz6rc130_assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134238.RArU3nKqsqfkEhyp5I8gXA2BlGbtmGlAz9tAG-exNz6rc130_provenance.